Genomic Valley Biotech Ltd — Results, 13-06-2025: Result

Genomic Valley Biotech Limited has announced a board meeting on which approved the financial results for the quarter and half-year ended March 31, 2025. The company reported revenue of ₹0.85 million and a net profit of ₹3.56 million for the year. It also appointed Mr. Yogainder Kumar Gupta as an Additional Independent Director for a five-year term and engaged M/s. SBR & Co. LLP as Secretarial Auditors for FY24-25. The board reconstituted key committees including Audit, Stakeholders' Relationship, Nomination & Remuneration, and Risk Management to strengthen governance.